HuzhouWeike New Material Technology Co., Ltd. – Trademark Portfolio

Entity Type: 16

HuzhouWeike New Material Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HEACARE. The owner is based in Zhejiang Province.

No. 7, Chuangye Avenue, Shangqiang Zone

Zhejiang Province 313000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HEACARE
HEACARE
Registered 2020

Trademark Classifications

HuzhouWeike New Material Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does HuzhouWeike New Material Technology Co., Ltd. have?

HuzhouWeike New Material Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does HuzhouWeike New Material Technology Co., Ltd. file in?

HuzhouWeike New Material Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are HuzhouWeike New Material Technology Co., Ltd.'s most well-known trademarks?

HuzhouWeike New Material Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as HEACARE. These are among 1 currently registered trademark in the portfolio.

What is HuzhouWeike New Material Technology Co., Ltd.'s trademark registration success rate?

HuzhouWeike New Material Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.